Central amygdala neuroimmune signaling in alcohol use disorder
Alcohol Use Disorder (AUD) is a prevalent and debilitating condition characterized by an inability to control alcohol consumption despite adverse consequences. Current treatments for AUD, including FDA-approved medications such as naltrexone and acamprosate, have limited efficacy and compliance, und...
Saved in:
Main Authors: | Mariam Melkumyan, Patrick A. Randall, Yuval Silberman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Addiction Neuroscience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772392524000531 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valence and salience encoding in the central amygdala
by: Mi-Seon Kong, et al.
Published: (2025-01-01) -
The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms
by: Wenli Jiao, et al.
Published: (2025-01-01) -
Basolateral amygdala volume in affective disorders using 7T MRI in vivo
by: Benedikt Kürzinger, et al.
Published: (2025-01-01) -
From Homeostasis to Neuroinflammation: Insights into Cellular and Molecular Interactions and Network Dynamics
by: Ludmila Müller, et al.
Published: (2025-01-01) -
The amygdala and the pursuit of future rewards
by: S. Tobias Johnson, et al.
Published: (2025-01-01)